REMED Co., Ltd. engages in the development and manufacture of medical devices related to electronic medication. The firm focuses on brain rehabilitation business that utilizes Transcranial Magnetic Stimulation for the purpose of non-invasive treatment and rehabilitation of brain diseases. It also specializes in chronic pain treatment business using Neuro Magnetic Stimulation and an aesthetic business using Core Muscle Strengthen Magnetic Stimulation to strengthen muscles. The company was founded on July 31, 2003 and is headquartered in Daejeon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company